KR102501636B9 - Tablet for oral administration comprising fenofibric acid and method for manufacturing same - Google Patents

Tablet for oral administration comprising fenofibric acid and method for manufacturing same

Info

Publication number
KR102501636B9
KR102501636B9 KR1020210173686A KR20210173686A KR102501636B9 KR 102501636 B9 KR102501636 B9 KR 102501636B9 KR 1020210173686 A KR1020210173686 A KR 1020210173686A KR 20210173686 A KR20210173686 A KR 20210173686A KR 102501636 B9 KR102501636 B9 KR 102501636B9
Authority
KR
South Korea
Prior art keywords
tablet
oral administration
manufacturing same
fenofibric acid
fenofibric
Prior art date
Application number
KR1020210173686A
Other languages
Korean (ko)
Other versions
KR102501636B1 (en
Inventor
황성주
이종주
고수진
김지은
Original Assignee
에이스바이오팜 주식회사
연세대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에이스바이오팜 주식회사, 연세대학교 산학협력단 filed Critical 에이스바이오팜 주식회사
Priority to KR1020210173686A priority Critical patent/KR102501636B1/en
Application granted granted Critical
Publication of KR102501636B1 publication Critical patent/KR102501636B1/en
Publication of KR102501636B9 publication Critical patent/KR102501636B9/en

Links

KR1020210173686A 2021-12-07 2021-12-07 Tablet for oral administration comprising fenofibric acid and method for manufacturing same KR102501636B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210173686A KR102501636B1 (en) 2021-12-07 2021-12-07 Tablet for oral administration comprising fenofibric acid and method for manufacturing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210173686A KR102501636B1 (en) 2021-12-07 2021-12-07 Tablet for oral administration comprising fenofibric acid and method for manufacturing same

Publications (2)

Publication Number Publication Date
KR102501636B1 KR102501636B1 (en) 2023-02-21
KR102501636B9 true KR102501636B9 (en) 2024-03-13

Family

ID=85328488

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210173686A KR102501636B1 (en) 2021-12-07 2021-12-07 Tablet for oral administration comprising fenofibric acid and method for manufacturing same

Country Status (1)

Country Link
KR (1) KR102501636B1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003013607A1 (en) * 2001-08-07 2003-02-20 Galephar M/F ORAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF FENOFIBRATE AND A HMG-CoA REDUCTASE INHIBITOR
BRPI0415121A (en) * 2003-10-10 2006-11-28 Lifecycle Pharma As particulate material, solid dosage form, method of manufacturing it, and use of a particulate material or solid dosage form
EA200701751A1 (en) 2005-03-30 2008-04-28 Тева Фармасьютикал Индастриес Лтд. IMPROVED PHENOPHIBRATE COMPOSITIONS
UA100966C2 (en) * 2005-04-08 2013-02-25 Эбботт Леборетриз Oral pharmaceutical formulation based on 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid
KR20110097168A (en) * 2010-02-24 2011-08-31 근화제약주식회사 New pharmaceutical composition for treatment of hyperlipidemia
KR101202994B1 (en) * 2010-04-12 2012-11-21 한미사이언스 주식회사 Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent
KR101925590B1 (en) * 2016-08-30 2018-12-05 대원제약 주식회사 Formulation of fenofibric acid with improved bioavailability

Also Published As

Publication number Publication date
KR102501636B1 (en) 2023-02-21

Similar Documents

Publication Publication Date Title
HRP20192119T1 (en) Composition and method for aiding sleep
PT2588090T (en) Pharmaceutical oral dosage forms comprising dabigatran etexilate and its pharmaceutically acceptable salts
MX2016004487A (en) Enteric soft capsules comprising polyunsaturated fatty acids.
SG10201506708UA (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
ZA202105976B (en) Pharmaceutical dosage form for application to mucous membranes and methods for producing same
EP3981400A4 (en) Oral capsule and preparation method therefor
SG10201901677YA (en) Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
PL3793534T3 (en) An oral tablet for delivery of active ingredients to the gastrointestinal tract
SI3003383T1 (en) Solid composition for oral administration containing ibandronic acid or a pharmaceutically acceptable salt thereof and vitamin d
SI2654729T1 (en) Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
KR102501636B9 (en) Tablet for oral administration comprising fenofibric acid and method for manufacturing same
WO2010081722A3 (en) Orally disintegrating tablets for the treatment of pain
EP3485876A4 (en) Oral pharmaceutical composition and method for producing particulate formulation comprising composition
EP3960240A4 (en) Pharmaceutical preparation and method for producing same
GB201910294D0 (en) Liquid pharmaceutical composition for oral administration comprising paracetamol and codeine phosphate
WO2015166419A3 (en) Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain
ZA202110948B (en) Pharmaceutical dosage forms and methods for their production
EP4117460C0 (en) Chewable product for oral delivery of a substance, and method of manufacturing the same
ZA202109079B (en) Β-ketosulfoxide derivative for carboxylic acid drugs as well as preparation method and application thereof
EP3969002A4 (en) Pharmaceutical composition of a weak acid drug and methods of administration
EP3941421A4 (en) Pharmaceutical packaging system and method of manufacturing same
GB201512436D0 (en) Method and production system for producing a pharmaceutical extrudate comprising a low-dose active pharmaceutical ingredient
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
MX2009001925A (en) Oral pharmaceutical composition for use in respiratory diseases.
JP2017515858A5 (en)

Legal Events

Date Code Title Description
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]